CALC is trading at $0.69 (10.2% up) after a sharp rebound from its prior close of $0.63, as investors continue to react to significant corporate developments.
- The stock's momentum follows the June 24 announcement of a private placement worth up to $49 million alongside a recent FDA-related update.
- This move marks a continuation of recent volatility, including a 4.84% rise on June 25, suggesting sustained trader interest in the company's capital raise and pipeline story.
- The gains appear to be company-specific rather than index-led, as CALC is trending higher despite broader market weakness.